OpenVSafe by OpenVAERS
Search V-safe

YB9-28300-28632

3 vaccinations 2 coded responses 18 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
496 / MI
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
H5J-12830-89223 Child or adolescent in my care · Female · 2022-06-29

Timeline

  1. 2021-03-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-19
    Registered in v-safe
  3. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  4. 2021-03-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-25
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-08
    Dose 2 — Pfizer-BioNTech
  12. 2021-06-17
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-09-18
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  14. 2022-03-18
    Survey response — 12 months, dose 1
    MedDRA: Fatigue, Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat Fatigue
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-06-28
    Dose 3 — Pfizer-BioNTech
  16. 2022-06-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness
    Adult check-in
  17. 2022-06-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Redness, Swelling · Nausea
    Adult check-in
  18. 2022-07-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness
    Adult check-in
  19. 2022-07-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  20. 2022-07-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  21. 2022-07-07
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2023-06-28
    Survey response — 12 months, dose 3
    MedDRA: Thyroiditis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-03-18Pfizer-BioNTech
22021-04-08Pfizer-BioNTech No
32022-06-28Pfizer-BioNTech No

Free text

Release 11 — 12 months, dose 1

2022-03-18

Symptoms: Sore throat Fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue · · ✓
SDOropharyngeal pain · · ✓
SDThyroiditis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…